The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy

Cory McLaughlin, Anthony I. Squillaro, Shadassa Ourshaliman, Ashley Song, Ashwini Lakshmanan, Giovanni Cucchiaro, Matthew Hall, Rita V. Burke, Lorraine I. Kelley-Quon

Research output: Contribution to journalArticle

Abstract

Purpose: The purpose of this study was to describe the frequency and variation of opioid use across hospitals in infants undergoing pyloromyotomy and to determine the impact of opioid use on postoperative outcomes. Methods: A retrospective cohort study (2005–2015) was conducted by using the Pediatric Health Information System (PHIS) database, including infants (aged <6 months) with pyloric stenosis who underwent pyloromyotomy. Infants with significant comorbidities were excluded. Opioid use was classified as a patient receiving at least 1 opioid medication during his or her hospital stay and categorized as preoperative, day of surgery, or postoperative (≥1 day after surgery). Outcomes included prolonged hospital length of stay (LOS; ≥3 days) and readmission within 30 days. Findings: Overall, 25,724 infants who underwent pyloromyotomy were analyzed. Opioids were administered to 6865 (26.7%) infants, with 1385 (5.4%) receiving opioids postoperatively. In 2015, there was significant variation in frequency of opioid use by hospital, with 0%–81% of infants within an individual hospital receiving opioids (P < 0.001). Infants only receiving opioids on the day of surgery exhibited decreased odds of prolonged hospital LOS (odds ratio [OR], 0.85; 95% CI, 0.78–0.92). Infants who received an opioid on both the day of surgery and postoperatively exhibited increased odds of a prolonged hospital LOS (OR, 1.71; 95% CI, 1.33–2.20). Thirty-day readmission was not associated with opioid use (OR, 1.03; 95% CI, 0.93–1.14). Implications: There is national variability in opioid use for infants undergoing pyloromyotomy, and postoperative opioid use is associated with prolonged hospital stay. Nonopioid analgesic protocols may warrant future investigation. (Clin Ther. 2019; 41:XXX–XXX)

Original languageEnglish (US)
JournalClinical Therapeutics
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Opioid Analgesics
Ambulatory Surgical Procedures
Length of Stay
Odds Ratio
Non-Narcotic Analgesics
Pyloric Stenosis
Health Information Systems
Comorbidity
Cohort Studies
Retrospective Studies
Databases
Pediatrics

Keywords

  • infant
  • opioid
  • pyloric stenosis
  • pyloromyotomy

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

McLaughlin, C., Squillaro, A. I., Ourshaliman, S., Song, A., Lakshmanan, A., Cucchiaro, G., ... Kelley-Quon, L. I. (Accepted/In press). The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2019.07.002

The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy. / McLaughlin, Cory; Squillaro, Anthony I.; Ourshaliman, Shadassa; Song, Ashley; Lakshmanan, Ashwini; Cucchiaro, Giovanni; Hall, Matthew; Burke, Rita V.; Kelley-Quon, Lorraine I.

In: Clinical Therapeutics, 01.01.2019.

Research output: Contribution to journalArticle

McLaughlin, C, Squillaro, AI, Ourshaliman, S, Song, A, Lakshmanan, A, Cucchiaro, G, Hall, M, Burke, RV & Kelley-Quon, LI 2019, 'The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy', Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2019.07.002
McLaughlin, Cory ; Squillaro, Anthony I. ; Ourshaliman, Shadassa ; Song, Ashley ; Lakshmanan, Ashwini ; Cucchiaro, Giovanni ; Hall, Matthew ; Burke, Rita V. ; Kelley-Quon, Lorraine I. / The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy. In: Clinical Therapeutics. 2019.
@article{38dc8429efaa42d2bfa0510503e8e1e9,
title = "The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy",
abstract = "Purpose: The purpose of this study was to describe the frequency and variation of opioid use across hospitals in infants undergoing pyloromyotomy and to determine the impact of opioid use on postoperative outcomes. Methods: A retrospective cohort study (2005–2015) was conducted by using the Pediatric Health Information System (PHIS) database, including infants (aged <6 months) with pyloric stenosis who underwent pyloromyotomy. Infants with significant comorbidities were excluded. Opioid use was classified as a patient receiving at least 1 opioid medication during his or her hospital stay and categorized as preoperative, day of surgery, or postoperative (≥1 day after surgery). Outcomes included prolonged hospital length of stay (LOS; ≥3 days) and readmission within 30 days. Findings: Overall, 25,724 infants who underwent pyloromyotomy were analyzed. Opioids were administered to 6865 (26.7{\%}) infants, with 1385 (5.4{\%}) receiving opioids postoperatively. In 2015, there was significant variation in frequency of opioid use by hospital, with 0{\%}–81{\%} of infants within an individual hospital receiving opioids (P < 0.001). Infants only receiving opioids on the day of surgery exhibited decreased odds of prolonged hospital LOS (odds ratio [OR], 0.85; 95{\%} CI, 0.78–0.92). Infants who received an opioid on both the day of surgery and postoperatively exhibited increased odds of a prolonged hospital LOS (OR, 1.71; 95{\%} CI, 1.33–2.20). Thirty-day readmission was not associated with opioid use (OR, 1.03; 95{\%} CI, 0.93–1.14). Implications: There is national variability in opioid use for infants undergoing pyloromyotomy, and postoperative opioid use is associated with prolonged hospital stay. Nonopioid analgesic protocols may warrant future investigation. (Clin Ther. 2019; 41:XXX–XXX)",
keywords = "infant, opioid, pyloric stenosis, pyloromyotomy",
author = "Cory McLaughlin and Squillaro, {Anthony I.} and Shadassa Ourshaliman and Ashley Song and Ashwini Lakshmanan and Giovanni Cucchiaro and Matthew Hall and Burke, {Rita V.} and Kelley-Quon, {Lorraine I.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.clinthera.2019.07.002",
language = "English (US)",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",

}

TY - JOUR

T1 - The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy

AU - McLaughlin, Cory

AU - Squillaro, Anthony I.

AU - Ourshaliman, Shadassa

AU - Song, Ashley

AU - Lakshmanan, Ashwini

AU - Cucchiaro, Giovanni

AU - Hall, Matthew

AU - Burke, Rita V.

AU - Kelley-Quon, Lorraine I.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: The purpose of this study was to describe the frequency and variation of opioid use across hospitals in infants undergoing pyloromyotomy and to determine the impact of opioid use on postoperative outcomes. Methods: A retrospective cohort study (2005–2015) was conducted by using the Pediatric Health Information System (PHIS) database, including infants (aged <6 months) with pyloric stenosis who underwent pyloromyotomy. Infants with significant comorbidities were excluded. Opioid use was classified as a patient receiving at least 1 opioid medication during his or her hospital stay and categorized as preoperative, day of surgery, or postoperative (≥1 day after surgery). Outcomes included prolonged hospital length of stay (LOS; ≥3 days) and readmission within 30 days. Findings: Overall, 25,724 infants who underwent pyloromyotomy were analyzed. Opioids were administered to 6865 (26.7%) infants, with 1385 (5.4%) receiving opioids postoperatively. In 2015, there was significant variation in frequency of opioid use by hospital, with 0%–81% of infants within an individual hospital receiving opioids (P < 0.001). Infants only receiving opioids on the day of surgery exhibited decreased odds of prolonged hospital LOS (odds ratio [OR], 0.85; 95% CI, 0.78–0.92). Infants who received an opioid on both the day of surgery and postoperatively exhibited increased odds of a prolonged hospital LOS (OR, 1.71; 95% CI, 1.33–2.20). Thirty-day readmission was not associated with opioid use (OR, 1.03; 95% CI, 0.93–1.14). Implications: There is national variability in opioid use for infants undergoing pyloromyotomy, and postoperative opioid use is associated with prolonged hospital stay. Nonopioid analgesic protocols may warrant future investigation. (Clin Ther. 2019; 41:XXX–XXX)

AB - Purpose: The purpose of this study was to describe the frequency and variation of opioid use across hospitals in infants undergoing pyloromyotomy and to determine the impact of opioid use on postoperative outcomes. Methods: A retrospective cohort study (2005–2015) was conducted by using the Pediatric Health Information System (PHIS) database, including infants (aged <6 months) with pyloric stenosis who underwent pyloromyotomy. Infants with significant comorbidities were excluded. Opioid use was classified as a patient receiving at least 1 opioid medication during his or her hospital stay and categorized as preoperative, day of surgery, or postoperative (≥1 day after surgery). Outcomes included prolonged hospital length of stay (LOS; ≥3 days) and readmission within 30 days. Findings: Overall, 25,724 infants who underwent pyloromyotomy were analyzed. Opioids were administered to 6865 (26.7%) infants, with 1385 (5.4%) receiving opioids postoperatively. In 2015, there was significant variation in frequency of opioid use by hospital, with 0%–81% of infants within an individual hospital receiving opioids (P < 0.001). Infants only receiving opioids on the day of surgery exhibited decreased odds of prolonged hospital LOS (odds ratio [OR], 0.85; 95% CI, 0.78–0.92). Infants who received an opioid on both the day of surgery and postoperatively exhibited increased odds of a prolonged hospital LOS (OR, 1.71; 95% CI, 1.33–2.20). Thirty-day readmission was not associated with opioid use (OR, 1.03; 95% CI, 0.93–1.14). Implications: There is national variability in opioid use for infants undergoing pyloromyotomy, and postoperative opioid use is associated with prolonged hospital stay. Nonopioid analgesic protocols may warrant future investigation. (Clin Ther. 2019; 41:XXX–XXX)

KW - infant

KW - opioid

KW - pyloric stenosis

KW - pyloromyotomy

UR - http://www.scopus.com/inward/record.url?scp=85070329817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070329817&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2019.07.002

DO - 10.1016/j.clinthera.2019.07.002

M3 - Article

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

ER -